# Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.

> **NCT00721695** · PHASE1,PHASE2 · COMPLETED · sponsor: **Omeros Corporation** · enrollment: 60 (actual)

## Conditions studied

- Cataract Extraction

## Interventions

- **DRUG:** OMS302
- **DRUG:** OMS302-PE
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT00721695
- **Lead sponsor:** Omeros Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721695, "Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00721695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*